Rectal ulcer in a hemodialysis patient receiving Sodium Polystyrene sulfonate ( Sodium Kayexalate®)

preprint OA: closed
View at publisher

Abstract

Kayexalate® is associated with gastrointestinal injury that can be fatal. Physicians must be aware of the adverse events when prescribing this therapy. Clinical data and medication history should follow the biopsy material given to the pathologist, who will look for Kayexalate® crystals. Pathologists and physicians should work hand in hand.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-05T02:00:03.366016+00:00